Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick#18 Annovis Bio; 6-Month Path Forward Possible For Buntanetap In AD, Q1 2025 Phase 3 Study Initiation And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #18 is a biotech by the name of Annovis Bio (ANVS)The reason why I wanted to go over this biotech next as ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Old Pick#4 Cardiff Oncology; Positive Onvansertib Data RAS Mutant mCRC, Additional Data From Same Study 1st Half 2025 And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #4 is a biotech by the name of Cardiff Oncology (CRDF). The reason why I wanted to go over this ...
Fierce Biotech

OpenAI launches biotech-specific AI model dubbed GPT-Rosalind

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to ...
Nasdaq

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...